ES2099318T3 - Procedimiento para la obtencion de formas farmaceuticas retardadas. - Google Patents

Procedimiento para la obtencion de formas farmaceuticas retardadas.

Info

Publication number
ES2099318T3
ES2099318T3 ES93109860T ES93109860T ES2099318T3 ES 2099318 T3 ES2099318 T3 ES 2099318T3 ES 93109860 T ES93109860 T ES 93109860T ES 93109860 T ES93109860 T ES 93109860T ES 2099318 T3 ES2099318 T3 ES 2099318T3
Authority
ES
Spain
Prior art keywords
procedure
landscuits
east
south
pharmaceutical forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93109860T
Other languages
English (en)
Inventor
Sven Dr Grabowski
Astrid Dr Kah-Helbig
Axel Dr Sanner
Kurt Dr Wendel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Application granted granted Critical
Publication of ES2099318T3 publication Critical patent/ES2099318T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

PROCEDIMIENTO PARA LA PRODUCCION DE FORMAS RETARDADAS SOLIDAS Y FARMACEUTICAS A TRAVES DE LA APLICACION DE UNAS DISPERSIONES ACUOSAS RECONSTITUYENTES DE EXCIPIENTES ACEPTABLES SOBRE NUCLEOS CONTENIENDO SUSTANCIAS ACTIVAS O A TRAVES DE GRANULACION EN HUMEDO DE LA SUBSTANCIA ACTIVA FARMACEUTICAMENTE CON UNA DISPERSION DE AGLOMERANTE O A TRAVES DE COMPRESION DIRECTA DE UNAS SUBSTANCIAS ACTIVAS EN EL POLVO DE EXCIPIENTE REDISPERSABLE. EL EXCIPIENTE SE OBTIENE A TRAVES DE POLIMERIZACION POR EMULSION Y A CONTINUACION SECADO POR ROCIADO DE LA DISPERSION ACUOSA OBTENIDA CON UNA SUBSTANCIA AUXILIAR ACEPTABLE FARMACEUTICAMENTE, SOLUBLE EN AGUA CON UNA TEMPERATURA VITREA DE POR LO MENOS 60 C Y MEDIO ANTIBLOQUE ACEPTABLE FARMACEUTICAMENTE.
ES93109860T 1992-06-25 1993-06-21 Procedimiento para la obtencion de formas farmaceuticas retardadas. Expired - Lifetime ES2099318T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4220782A DE4220782A1 (de) 1992-06-25 1992-06-25 Verfahren zur Herstellung von festen pharmazeutischen Retardformen

Publications (1)

Publication Number Publication Date
ES2099318T3 true ES2099318T3 (es) 1997-05-16

Family

ID=6461767

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93109860T Expired - Lifetime ES2099318T3 (es) 1992-06-25 1993-06-21 Procedimiento para la obtencion de formas farmaceuticas retardadas.

Country Status (10)

Country Link
US (1) US5490990A (es)
EP (1) EP0575930B1 (es)
JP (1) JP3619531B2 (es)
AT (1) ATE149826T1 (es)
CA (1) CA2098667C (es)
DE (2) DE4220782A1 (es)
DK (1) DK0575930T3 (es)
ES (1) ES2099318T3 (es)
GR (1) GR3023242T3 (es)
MX (1) MX9303604A (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4341156C2 (de) * 1993-12-02 1997-11-13 Wacker Chemie Gmbh Verwendung von in Wasser redispergierbaren Kunststoffdispersionspulvern als Arzneimittelträger
WO1997006787A2 (en) * 1995-08-17 1997-02-27 Dyer, Alison, Margaret Controlled release products
JPH1050306A (ja) * 1996-07-31 1998-02-20 Toyota Autom Loom Works Ltd 水素吸蔵合金電極の製造方法
AT403914B (de) * 1996-09-24 1998-06-25 Krems Chemie Ag Sprühgetrocknete dispersionen, verfahren zu ihrer herstellung und deren anwendung
DE19709663A1 (de) * 1997-03-10 1998-09-17 Basf Ag Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten als Bindemittel zur Herstellung von festen pharmazeutischen Darreichungsformen
DE19709532A1 (de) * 1997-03-10 1998-09-17 Basf Ag Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten zum Überziehen von pharmazeutischen oder agrochemischen Darreichungsformen
ATE526950T1 (de) * 1999-10-29 2011-10-15 Euro Celtique Sa Hydrocodon-formulierungen mit gesteuerter freisetzung
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
JP5767429B2 (ja) * 1999-11-12 2015-08-19 アッヴィ・インコーポレイテッド 固体分散剤中の結晶化阻害剤
GT200100039A (es) * 2000-03-16 2001-12-31 Pfizer Inhibidor de la glucogeno fosforilasa.
DE10014588A1 (de) * 2000-03-27 2001-10-04 Basf Ag Wirkstoffhaltige Schwimmformen enthaltend Polyvinylacetat und Polyvinylpyrrolidon, deren Verwendung und Herstellung
DE10015479A1 (de) * 2000-03-29 2001-10-11 Basf Ag Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität
US6399101B1 (en) 2000-03-30 2002-06-04 Mova Pharmaceutical Corp. Stable thyroid hormone preparations and method of making same
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US8257744B2 (en) * 2000-07-07 2012-09-04 Laboratorios Farmacéuticos Rovi, S.A. Pharmaceutical forms for the release of active compounds
FR2811227A1 (fr) * 2000-07-07 2002-01-11 Philippe Maincent Vecteurs particulaires destines a ameliorer l'absorption orale de principes actifs
EP2263658A1 (en) 2000-10-30 2010-12-22 Euro-Celtique S.A. Controlled release hydrocodone formulations
US20030099699A1 (en) 2001-11-13 2003-05-29 Hanshew Dwight D. Storage stable thyroxine active drug formulations and methods for their production
US6645526B2 (en) * 2001-11-13 2003-11-11 Mylan Pharmaceuticals, Inc. Storage stable thyroxine active drug formulations and methods for their production
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
EP1711535A4 (en) * 2004-02-05 2008-10-15 Lg Chemical Ltd METHOD OF EMULSION POLYMERIZATION USING A LIQUID MINIEMULSION AS SEED PARTIES
AU2005240137B2 (en) * 2004-05-04 2010-04-15 Innophos, Inc. Directly compressible tricalcium phosphate
US8168219B2 (en) * 2005-11-30 2012-05-01 Isp Investments Inc. Synergistic binder composition, method for making same, and tablets of an active and said binder having advantageous hardness and friability
WO2008067164A2 (en) * 2006-11-15 2008-06-05 Abbott Laboratories Solid pharmaceutical dosage formulations
US8802156B2 (en) 2007-11-14 2014-08-12 Laboratorios Farmacéuticos Rovi, S.A. Pharmaceutical forms for the release of active compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE27107E (en) * 1968-05-01 1971-03-30 Drug composition
US3784648A (en) * 1971-10-01 1974-01-08 Wacker Chemie Gmbh Process for the preparation of free-flowing,lump-free,redispersible,synthetic resin powders
DE3013839A1 (de) * 1979-04-13 1980-10-30 Freunt Ind Co Ltd Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
DE3143071A1 (de) * 1981-10-30 1983-05-11 Basf Ag, 6700 Ludwigshafen Verfahren zum herstellen von blockfesten, in wasser redispergierbaren polymerisat-pulvern durch verspruehen von waessrigen polymerisat-dispersionen
LU85058A1 (fr) * 1983-10-24 1985-06-19 Pharlyse Comprimes pharmaceutiques a liberation prolongee,leur preparation et leur utilisation
DE3344242A1 (de) * 1983-12-07 1985-06-20 Wacker-Chemie GmbH, 8000 München Verfahren zur herstellung eines redispergierbaren dispersionspulvers und seine anwendung
DE3438291A1 (de) * 1984-10-19 1986-04-24 Röhm GmbH, 6100 Darmstadt Verfahren zur herstellung einer waessrigen ueberzugsmitteldispersion und ihre verwendung zum ueberziehen von arzneimitteln
DE3719241A1 (de) * 1987-06-06 1988-12-15 Roehm Gmbh Spruehgetrocknetes emulsionspolymerisat, verfahren zu seiner herstellung und verwendung und daraus bereitete formmasse
DE3723668A1 (de) * 1987-07-17 1989-01-26 Roehm Gmbh Staubarmes spruehgetrocknetes emulsionspolymerisat und verfahren zu seiner herstellung und anwendung
US5025004A (en) * 1988-06-13 1991-06-18 Eastman Kodak Company Water-dispersible polymeric compositions
DE3923229A1 (de) * 1989-07-14 1991-01-24 Basf Ag In wasser redispergierbare polymerisat-pulver, die durch verspruehen von waessrigen polymerisat-dispersionen hergestellt sind, und ihre verwendung als zusatzmittel zu hydraulischen bindemitteln
DE4133192A1 (de) * 1991-10-07 1993-04-08 Basf Ag Verfahren zum ueberziehen von arzneiformen

Also Published As

Publication number Publication date
GR3023242T3 (en) 1997-07-30
US5490990A (en) 1996-02-13
JP3619531B2 (ja) 2005-02-09
DK0575930T3 (da) 1997-04-01
DE59305700D1 (de) 1997-04-17
DE4220782A1 (de) 1994-01-05
CA2098667A1 (en) 1993-12-26
CA2098667C (en) 2003-10-28
ATE149826T1 (de) 1997-03-15
EP0575930A1 (de) 1993-12-29
JPH0656651A (ja) 1994-03-01
MX9303604A (es) 1994-06-30
EP0575930B1 (de) 1997-03-12

Similar Documents

Publication Publication Date Title
ES2099318T3 (es) Procedimiento para la obtencion de formas farmaceuticas retardadas.
CA2027592A1 (en) Solid pharmaceutical preparations of active form of vitamin d_ of improved stability
FR2779648B1 (fr) Composition cosmetique ou pharmaceutique se presentant sous forme de solide et pouvant etre deformable
IT7928301A0 (it) Forme galeniche di somministrazione di medicamenti per via orale,a liberazione programmata,e loro procedimenti di preparazione
DE59009074D1 (de) Diarylsubstituierte heterocyclische Verbindung, ihre Herstellung und Arzneimittel und Kosmetika daraus.
MX9205823A (es) Formulaciones de liberacion controlada estabilizada que tienen un revestimiento de polimero acrilico.
EP0382066A3 (de) Verwendung von Dihydroliponsäure als Analgetikum, Antiphlogistikum und/oder Zytoprotektivum
UY23958A1 (es) Procedimiento para la preparación de formas de dosificación de liberación controlada de azitromicina
GB1465781A (en) Pharmaceutical preparations
DE69807104D1 (de) Formulierungen mit gesteuerter freisetzung
BR9913782A (pt) Processo de preparação de uma formualação galênica que compreende fenofibrato como princìpio ativo, formulação galênica, medicamento e utilizações de um meio lìquido e de partìculas de fenofibrato
ATE86855T1 (de) Galenische formen des verapamils, deren herstellung sowie diese enthaltende arzneimittel.
IT1265001B1 (it) Composizione farmaceutica per uso topico contenente acido (s)-2-(4- isobutilfenil) propionico
ES2108129T3 (es) Nuevos derivados de pirazina, su preparacion y empleo.
ATE273002T1 (de) Feste lösung eines fungizids mit erhöhter bioverfügbarkeit
DE69904701D1 (de) Physiologisch aktives polypeptid enthaltende zubereitung mit verzögerter freisetzung und deren herstellung
ES2060558T3 (es) Producto para la fijacion del cabello.
ES2038605T3 (es) Un metodo para la produccion de una preparacion de tipo no liquido para inyeccion.
ATE161872T1 (de) Im wesentlichen reines synthetisches melanin, besonders geeignet fuer optische vorrichtungen von geringer truebung
ES553069A0 (es) Procedimiento para la preparacion de un polvo para heridas, libremente fluyente, homogeneo, conteniendo yodoforo
IE790259L (en) Aqueous pharmaceutical solution
BG60015B2 (bg) Метод за получаване на 3-метокси-4-/1-метил-5- /2-метил-4,4,4-трифлуорбутилкарбамоил/индол-3- ил-метил/-n-/2-метилфенилсулфонил/бензамид
JPS5340779A (en) Optically active tolpertisone, their preparation and pharmaceuticals containting the same
IT1094899B (it) 4-fenil-8-amino-tetraidroisochinoline,preparati farmaceutici contenenti tali sostanze,processo per la preparazione di questi preparati e loro impiego come antide pressivi
EP0056681A3 (en) Levonantradol and n-methyllevonantradol formulations

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 575930

Country of ref document: ES